Sci-Tech Bio Reports Interim Net Profit of 25.10 Million Yuan, Down 39.09% Year-on-Year

Jiemian··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Sci-Tech Bio released its 2026 interim report, with net profit attributable to the parent company at 25.10 million yuan, down 39.09% from the same period last year. Total operating revenue was 170 million yuan, and net cash flow from operating activities was 10.16 million yuan, down 63.55% year-on-year. The latest asset-liability ratio was 11.64%, gross margin was 47.09%, return on equity was 1.40%, and diluted earnings per share was 0.10 yuan.

Impact on assets 1

Others▼ · 1 stocks
© 2026 MarketIVNews